Tadataka Yamada, Director at Passage BIO, Inc. (PASG), bought 6,500 shares at $18.00 ($117K) on 2020-03-03, disclosed to the SEC on 2020-03-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.